RBC Capital Upgrades Cardiome Pharma (CRME) to Outperform
Go back to RBC Capital Upgrades Cardiome Pharma (CRME) to Outperform| Cardiome Pharma Corporation (NASDAQ: CRME) | Delayed: 2.13 +0.08 (3.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.05 | 52 Week High | $7.10 | |||
| Open | $2.05 | 52 Week Low | $1.86 | |||
| Day High | $2.15 | P/E | N/A | |||
| Day Low | $2.05 | EPS | $0.00 | |||
| Volume | 205,351 | |||||
